Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesFisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetesTargeting Reactive Carbonyl Species with Natural Sequestering AgentsPharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseasePeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesCoronary artery revascularization in patients with diabetes mellitusRAGE controls activation and anti-inflammatory signalling of protein CRAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activationMethylglyoxal evokes pain by stimulating TRPA1Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using TranilastPhosphoproteome Analysis Reveals Phosphorylation Underpinnings in the Brains of Nurse and Forager Honeybees (Apis mellifera)Systemic activation of NF-κB driven luciferase activity in transgenic mice fed advanced glycation end products modified albumin.The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies.Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study.A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation.Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.The glomerulus--a view from the outside--the podocyte.RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner.Diabetic neuropathy: clinical manifestations and current treatments.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancerTrafficking of phagocytic peritoneal cells in hypoinsulinemic-hyperglycemic mice with systemic candidiasisEvidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchangeAdvanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancerModeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processesTotal soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trialMaternal plasma protein profiles in response to oral 50-gram glucose load in mid-pregnancy: a pilot studyInfluence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly SubjectsEarly- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-study).Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.AGEs-Induced IL-6 Synthesis Precedes RAGE Up-Regulation in HEK 293 Cells: An Alternative Inflammatory Mechanism?Post-translational modifications of voltage-gated sodium channels in chronic pain syndromesTargeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression.Soluble receptor for advanced glycation end products and risk of liver cancer.Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines.
P2860
Q21285070-EEED1657-9927-4AFC-80E1-4E8B933715B7Q21560804-9C3FC413-7A19-4CB2-8084-2E53AE79C13DQ26765482-84B5691E-E4B1-486F-B49C-AB27A9DE96E1Q26782422-AB371842-44AD-4B2C-ACD0-9488044B8D7EQ26799591-30069574-19C8-47BB-B549-1F136483FED1Q26824002-621D0F23-801A-4F8E-B5C2-838AE3383C87Q27320852-F25651A8-8A09-4976-948B-B6F37A73C178Q28482199-7A27A789-137B-4BCD-AD25-B9D44B5D9C58Q28534579-40638DB8-866B-4987-BC2B-6C5A73888B6EQ28553904-2480AB6E-1901-4E8D-9654-218A9F46E5F8Q29994682-D77B2AE2-B2EC-4117-B20A-B9E22726E4EBQ30313434-C75B8ACF-5C2A-4DB6-A678-80AADBE9B440Q33350900-2D62DF69-4112-44BA-A3B7-DCE42CA85A0FQ33592848-E12EDE7B-EBFF-4A2F-853F-DF81DD3281F6Q33594667-CFDE4897-53B2-4B1F-9C7B-FD9A1FF3C84DQ33710953-0DDB1052-936A-41A3-9CAD-7830DD8E0199Q33722124-D8E2A052-E28A-4B57-B819-735AAA38F5EDQ33890233-6C50B1BA-F4F7-4B95-BFB3-C37D38517FF8Q34020798-CFFF408E-2582-4137-88BB-BF2A2704C3B4Q34039810-623CEA51-E406-47EA-BE1C-5D9FA7366201Q34275990-EAB68220-5DFF-4496-ABA0-F621F34F1778Q34350546-6A4D8622-A86B-4703-8900-765CD06236D4Q34426525-00E697D1-F8C3-4E03-A2BB-8348AAD8C39BQ34632356-943D524A-AC00-4DB0-9748-C0B56716B23CQ34987953-EBDA4DAD-D50B-4D7E-B3FE-9F35F10A1DEFQ35009387-D50CD83D-5AB3-4358-B338-1C44C27EE45AQ35093747-22CE1B58-9138-4E18-8F76-4CD31A534E44Q35163077-6B0F8073-59D0-46E6-B9B4-71030392C10DQ35180065-56102093-0EAD-4091-864D-518386AE93A7Q35193846-BFFE7028-FB9C-42CE-82D3-71CD0F2FD58CQ35756983-D7A86231-CA5F-4EB4-8D8D-A361CB3218E6Q35809946-2312CADD-635D-46C7-BB79-5AE2785E0F93Q35898181-A2FC0108-BBAD-4712-A97D-81842CDACCE3Q35914764-5E0CF15D-BCDA-4934-BD7D-DF263027B604Q36166108-8A5558C8-9559-4330-93CE-F444961D38C1Q36183895-059C4C3F-1D9C-4D16-A4EA-A6307AE9E130Q36249467-85E299B4-9084-4EA9-AF8E-E7E7B43E7715Q36498317-C578AF3D-E6D1-4283-B659-8DA1F5CBA197Q36816945-B61D6B1F-CC8A-4037-AFE0-847663C92F92Q36820542-067DB6A5-5999-4776-B42C-FB10F372D895
P2860
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiple levels of regulation ...... ellitus and its complications.
@en
Multiple levels of regulation ...... ellitus and its complications.
@nl
type
label
Multiple levels of regulation ...... ellitus and its complications.
@en
Multiple levels of regulation ...... ellitus and its complications.
@nl
prefLabel
Multiple levels of regulation ...... ellitus and its complications.
@en
Multiple levels of regulation ...... ellitus and its complications.
@nl
P2860
P1433
P1476
Multiple levels of regulation ...... ellitus and its complications.
@en
P2093
A Bierhaus
P P Nawroth
P2860
P2888
P304
P356
10.1007/S00125-009-1458-9
P577
2009-07-28T00:00:00Z